CUSIP: 68232V884 | NYSE | Healthcare · Biotechnology | Micro Cap | 60 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 110,970 | $65.9K | 0.0% | Index | Very Low | Boston, MA | 2026-11-06 | |
| 11,761 | $7.0K | 0.0% | Core | Medium | New York, NY | 2026-11-04 | |
| 11,106 | $5.3K | 0.0% | ETF | Medium | New York, NY | 2026-11-03 | |
| 1,723 | $1.0K | 0.0% | Agg Growth | Low | Tokyo, Mexico | 2026-10-22 |
| No 13F filer matched |
| 13G/AAdage Capital Management, L.P. | 730,000 | 4.8% | Newly reported | Jun 30, 2026 | No 13F filer matched |
| 13G/ASquadron Capital Management LLC | 0 | 0.0% | No shares held | Jun 30, 2026 | 511,714 sh (Mar 31, 2026) |